Lubazodone

Lubazodone
Systematic (IUPAC) name
	(2S)-2-[(7-fluoro-2,3-dihydro-1H-inden-4-yl)oxymethyl]morpholine
Clinical data
Legal status	Uncontrolled;
Routes of; administration	Oral
Identifiers
CAS Number	161178-07-0
ATC code	None
PubChem	CID 157919
ChemSpider	138947
UNII	850TB2B172
Chemical data
Formula	C14H18FNO2
Molar mass	251.296 g/mol
	SMILES C1CC2=C(C=CC(=C2C1)F)OC[C@@H]3CNCCO3 ;
	InChI InChI=1S/C14H18FNO2/c15-13-4-5-14(12-3-1-2-11(12)13)18-9-10-8-16-6-7-17-10/h4-5,10,16H,1-3,6-9H2/t10-/m0/s1 ; Key:HTODIQZHVCHVGM-JTQLQIEISA-N ;
(what is this?) (verify)

Lubazodone (YM-992, YM-35,995) is an experimental antidepressant which was being developed as a treatment for depression and obsessive compulsive disorder, and reached phase II clinical trials, but was discontinued. It acts as a serotonin reuptake inhibitor and 5-HT_2A receptor antagonist.

References[edit]

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.